NA
ETON icon

NewEdge Advisors’s Eton Pharmaceutcials ETON Stock Holding History

NewEdge Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-252
Closed -$1.1K – 3864
2023
Q4 		$1.1K Buy
252
+77
+44% +$309 ﹤0.01% 3451
2023
Q3 		$730 Buy
+175
New +$676 ﹤0.01% 3212

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NewEdge Advisors's ETON Position: Q1 2024 in Review

NewEdge Advisors sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 252 shares — an estimated $1.1K sold.

NewEdge Advisors first reported a position in ETON in Q3 2023 and held it in 2 quarters. The position peaked at $1.1K in Q4 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • NewEdge Advisors reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • NewEdge Advisors sold 252 Eton Pharmaceutcials shares in Q1 2024, an estimated $1.1K.
  • NewEdge Advisors first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 2 quarters.
  • NewEdge Advisors's Eton Pharmaceutcials position peaked at $1.1K in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on NewEdge Advisors's 13F filing for Q1 2024, filed 14 May 2024.